Is This the Right Time to Retain Omnicell Stock in Your Portfolio?Zacks Investment Research · Oct 13, 2026
Financial Contrast: Baxter International (NYSE:BAX) and Omnicell (NASDAQ:OMCL)Defense World · Oct 11, 2026
Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026Business Wire · Oct 8, 2026
Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research · Oct 2, 2026
Here's Why Omnicell (OMCL) is a Strong Value StockZacks Investment Research · Sep 16, 2026
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy OperationsPRNewsWire · Sep 3, 2026Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 30, 2026 | $0.47 | $0.94 | Beat |
| Apr 28, 2026 | $0.33 | $0.55 | Beat |
| Feb 5, 2026 | $0.47 | $0.40 | Miss |
| Oct 30, 2025 | $0.36 | $0.51 | Beat |
| Jul 31, 2025 | $0.31 | $0.45 | Beat |
| May 6, 2025 | $0.16 | $0.26 | Beat |